Immunohistochemistry on 170 human Ewing’s sarcoma samples revealed that CCN3 was more highly expressed in recurrences (6/8) and metastases (8/10) when compared to the primary tumor (79/152). The gene discussed is CCN3; the disease is Ewing sarcoma.